Sudarshan Pharma Industries Limited
Bookbuilding IPO · BSE
- Price band
- ₹71 - ₹73
- Lot size
- 1,600 shares
- Issue amount
- ₹50.1 cr
- Total subscription
- 1.06×
- Opens
- 9 Mar 2023
- Closes
- 14 Mar 2023
- Allotment
- 18 Mar 2023
- Listing
- 20 Mar 2023
Offer at a glance
Issue overview
- Issue size
- 68,62,400 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,13,600
- Fresh issue
- ₹50.1 cr
- Offer for sale
- ₹0 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,16,800
- Issue type
- Bookbuilding IPO
- Shares before issue
- 95,46,998
- Shares after issue
- 1,29,86,998
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,600 | ₹1,16,800 |
| HNI | 2 | 3,200 | ₹2,33,600 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 2008, Sudarshan Pharma Industries Limited (SPIL) is a Mumbai-based company engaged in contract manufacturing, import, export, and supply of specialty chemicals, Active Pharmaceutical Ingredients (APIs), and intermediates. The company sources and supplies generic formulations by outsourcing manufacturing facilities from domestic and international suppliers based on client requirements. Its products find applications across industries such as pharmaceuticals, paints, food, and adhesives. SPIL also supplies medicines and pharma formulations to hospitals, NGOs, government bodies, and healthcare institutions under its own brand, offering around 50 formulations in tablets, capsules, ointments, and injectables. With a strong sales and distribution network across five states, the company markets its products ethically in both Indian and international markets, while also offering formulation development, quality control, and customized pharma solutions.
Strengths
- Customer-focused, order-driven model.
- Wide product portfolio.
- Contract manufacturing capabilities.
- Strong distribution & sales network.
- Diversified operations.
Promoters
Mr. Hemal Vasantrai Mehta
Mr. Sachin Vasantrai Mehta
Registrar & documents
Lead manager
Gretex Corporate Services Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
301,3rd Floor, Aura Biplex, Above Kalyan Jewellers S. V. Road, Borivali (West) Mumbai - 400092
022- 42221111
[email protected]Company website ↗Understanding SUDARSHAN IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.